ET
EIKONOKLASTES THERAPEUTICS, INC.
SEC filingPharmaceuticals · Cincinnati, OH
Amount raised$13.6Msold at filing
Total offering$15.8M$2.2M still open
Investors in the raise14count reported to the SEC
FiledJul 29, 2025first sale Jul 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas FinnDirector
Joseph NolanDirector
Robert JohnsonDirector
Samuel LeeExecutive Officer, Director
Bruce HalprynExecutive Officer, Director
Kenneth MorandDirector
Executive officers, directors and promoters as listed on the Form D.